[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352152-105":59,"doc-detail-352152-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","chitosan-based-nanoparticles-as-a-targeted-drug-delivery-system-to-treat-thyroid-cancer-a-literature-review","Chitosan-based Nanoparticles as a Targeted Drug Delivery System to Treat Thyroid Cancer - A Literature Review","","Systemic toxicity, poor drug selectivity, resistance, and inconsistent tumor responses constrain thyroid cancer treatment. This literature review focuses on chitosan-based nanoparticles (ChNPs) as nanocarriers for targeted drug delivery, leveraging mucoadhesion, biodegradability, biocompatibility, and simple surface modification. It synthesizes recent advances in design, functionalization, and therapeutic use, highlighting ligand conjugation, PEGylation, and stimuli-responsive linkers to improve stability, uptake, circulation, selectivity, and efficacy.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/chitosan-based-nanoparticles-as-a-targeted-drug-delivery-system-to-treat-thyroid-cancer-a-literature-review/352152/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/chitosan-based-nanoparticles-as-a-targeted-drug-delivery-system-to-treat-thyroid-cancer-a-literature-review/352152.png","ImageObject",300,407,{"name":92,"@type":93},"CatatanPagi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-13","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why are chitosan-based nanoparticles considered promising for thyroid cancer drug delivery?","Question",{"text":113,"@type":114},"Chitosan-based nanoparticles can enhance targeted delivery by providing mucoadhesion, biodegradability, biocompatibility, and enabling straightforward surface modification to improve how drugs are delivered and taken up by tumor-related cells.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which nanoparticle design strategies improve stability and therapeutic performance?",{"text":118,"@type":114},"The review highlights physicochemical modifications such as ligand conjugation, PEGylation, and stimuli-responsive linkers that support nanoparticle stability, cellular uptake, circulation time, and therapeutic efficacy.",{"name":120,"@type":111,"acceptedAnswer":121},"What limits clinical translation of chitosan-based nanoparticle therapies?",{"text":122,"@type":114},"Challenges include difficulties with large-scale production, regulatory approval, and the need for long-term safety evaluation, which currently hinder broader clinical adoption.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},352152,1790219171,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":36,"preview_page_count":19,"preview_urls":146},962090894170,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","®  \n Bibliometric Review   \nChitosan-based nanoparticles as a targeted drug delivery system to treat thyroid cancer A literature review  \nHamad S. Alyami, PhDa ,b ,* , Nora A. Ahmadi, BScc ,d  \n\n| Abstract\u003Cbr>Background: Systemic toxicity, poor drug selectivity, treatment resistance, and inconsistent tumor responses are some of the therapeutic issues related to thyroid cancer (TC) . Chitosan-based nanoparticles (ChNPs) have shown promise as nanocarriers for target drug delivery due to their mucoadhesive qualities, biodegradability, biocompatibility, and simplicity of surface modification. Methods: With an emphasis on their role in enhancing drug delivery and targeting efficiency, this review compiled the literature on recent developments in the design, functionalization, and use of ChNPs for TC therapy.\u003Cbr>Results: According to available data, physicochemical changes such as ligand conjugation, PEGylation, and stimuli-responsive linkers can support the stability, cellular uptake, circulation time, and therapeutic efficacy of NPs. ChNPs can deliver anticancer drugs to thyroid carcinoma cells with greater selectivity by utilizing both active targeting through ligand-mediated interactions and passive targeting through the increased permeability and retention effect. When compared to traditional therapeutic methods, preclinical research has shown better boosted antitumor activity, medication absorption, and dimensioned systemic toxicity. However, difficulties with large-scale production, regulatory approval, and long-term safety evaluation continue to hinder clinical translation.\u003Cbr>Conclusion: Although further translational and clinical research is required to confirm ChNPs’ safety and efficacy in standard clinical practice, they offer a promising platform for targeted TC treatment.\u003Cbr>Abbreviations: AI = artificial intelligence, ATC = anaplastic thyroid carcinoma, BSA = bovine serum albumin, ChNPs = chitosanbased nanoparticles, CMCS = carboxymethyl chitosan, DD = degree of deacetylation, DDS = drug delivery system, DOX = doxorubicin, DTC = differentiated thyroid cancer, EE = encapsulation efficiency, EPR = enhanced permeability and retention, FTC = follicular thyroid carcinoma, GC = glycol chitosan, HA = hyaluronic acid, LC = loading capacity, MTC = medullary thyroid carcinoma, MW = molecular weight, NDDS = nanodrug delivery system, NPs = nanoparticles, PEG = polythylene glycol, PNP = polymeric nanoparticle, PTC = papillary thyroid carcinoma, PTMC = papillary thyroid microcarcinoma, RAI = radioactive iodine, RET = rearranged during transfection, ROS = reactive oxygen species, SEM = scanning electron microscopy, TC = thyroid cancer, TME = tumor microenvironment, TPP = tripolyphosphate, TSHR = thyroid-stimulating hormone receptor. |\n| --- |\n| Keywords: chitosan-based nanoparticles, drug delivery system, nanomedicine, thyroid cancer |\n\n1. Introduction  \n1.1. Structure and function of the thyroid gland The thyroid gland,“a butterfly-shaped endocrine organ in the anterior neck,”is responsible for the synthesis and secretion of the triiodothyronine (T3) and thyroid hormones thyroxine (T4). Both T3 and T4 hormones are important for physiological processes in the body, including growth and metabolism. The anatomical structure of the thyroid gland is demonstrated in Figure 1. [1]  \nThe authors are thankful to the Deanship of Graduate Studies and Scientific Research at Najran University for funding this work under the Student Research Funding Program grant code (NU/SRP/MRC/14/683-1).  \nThe authors have no conflicts of interest to declare.  \nAll data generated or analyzed during this study are included in this published article (and its supplementary information files).  \na Department of Pharmaceutics, College of Pharmacy, Najran University, Najran, Saudi Arabia, b Health Research Center, Najran University, Najran, Saudi Arabia, c Department of Chemistry, College of Science and Arts, Najran University, Najran, Saudi Arabia, d Creativity in","cbCaigQ33o1ydCCE","https://ap.wps.com/l/cbCaigQ33o1ydCCE","pdf",1611886,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# 1. Introduction\n## 1.1. Structure and function of the thyroid gland\n## 1.2. Thyroid cancer: epidemiology, incidence, and classification","[{\"question\":\"Why are chitosan-based nanoparticles considered promising for thyroid cancer drug delivery?\",\"answer\":\"Chitosan-based nanoparticles can enhance targeted delivery by providing mucoadhesion, biodegradability, biocompatibility, and enabling straightforward surface modification to improve how drugs are delivered and taken up by tumor-related cells.\"},{\"question\":\"Which nanoparticle design strategies improve stability and therapeutic performance?\",\"answer\":\"The review highlights physicochemical modifications such as ligand conjugation, PEGylation, and stimuli-responsive linkers that support nanoparticle stability, cellular uptake, circulation time, and therapeutic efficacy.\"},{\"question\":\"What limits clinical translation of chitosan-based nanoparticle therapies?\",\"answer\":\"Challenges include difficulties with large-scale production, regulatory approval, and the need for long-term safety evaluation, which currently hinder broader clinical adoption.\"}]","Chitosan-based Nanoparticles as a Targeted Drug Delivery System to Treat Thyroid Cancer - A Literature Review | PDF",1790097980,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45dbfb4b7eb464b69c24f05f7e3ca1e0.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9bf875b83df478f101917bec6ed48037.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de409c7af8c5f786cb0f9484e446b58f.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9fa8d56b7f68499b50c1b9caa963ab5d.webp",980,1306]